Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782581 · ClinicalTrials.gov registry record · NA
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
A NA study of Neoplasm, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 1
- Study location
NCT06782581: Recruiting NA study of Neoplasm, sponsored by Fox Chase Cancer Center.
NCT06782581 is a NA study of Neoplasm that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 186 participants, roughly in line with the 185-participant average among 11 other Neoplasm trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06782581, a NA study of Neoplasm, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which have been shown to be associated with psychological benefits according to self-determination theory.
Primary Outcome
Primary Outcome Measure: affective well-being scores range from 0-6, with 6 indicating higher negative or positive affect
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Contribution to Caregivers Well-Being
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2027-02-15 |
| Phase | NA |
What NCT06782581 shows while recruiting
NCT06782581 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 185-participant average among 11 other Neoplasm trials with a reported enrollment target.
The record links to 1 condition, with Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06782581 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06782581 about?
NCT06782581 is a clinical study titled "CARE Study: Cancer, Asian Americans, and Relationship Enrichment". The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which ...
What is the current status of trial NCT06782581?
This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2024-08-06. Estimated completion is 2027-02-15.
What conditions does trial NCT06782581 study?
This clinical trial studies the following conditions: Neoplasm.
What interventions are being tested in trial NCT06782581?
The interventions under investigation include: Control (BEHAVIORAL), Contribution to Caregivers Well-Being (BEHAVIORAL).
Who is sponsoring clinical trial NCT06782581?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782581 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06782581's enrollment target sits among peer trials
186 4th of 11 higher than 8 of 11 other Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
RECRUITING · NA
-
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RECRUITING · Phase 1
-
A Study of LY2835219 in Participants With Cancer
COMPLETED · Phase 1
-
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma
COMPLETED · Phase 2
-
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
COMPLETED · Phase 1
-
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI